NCT00538603已完成不适用
Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
- 主要终点
- overall survival
研究概览
简要总结
Multi-national, randomized, phase III, GCIG Intergroup study comparing pegylated liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in patients with epithelial ovarian cancer in late relapse. (CALYPSO)
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with epithelial Ovarian cancer in late relapse
排除标准
- 未提供
结局指标
主要结局
overall survival
时间窗: overall
次要结局
未报告次要终点
研究者
Dr. Naeem A. Chaudhri
Principal Investigator
King Faisal Specialist Hospital & Research Center
相似试验
Unknown
2 期
Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast CancerMetastatic Breast CancerNCT01451580TTY Biopharm47
已完成
2 期
Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast CancerBreast CancerNCT00960336ARCAGY/ GINECO GROUP59
已完成
不适用
Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian CancerOvarian CarcinomaNCT03562533Konkuk University Medical Center432
已完成
3 期
Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late RelapseFallopian Tube CancerOvarian CancerNCT00189553ARCAGY/ GINECO GROUP976
Unknown
2 期
Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung CancerNon-small Cell Lung CancerNCT01051362The First Affiliated Hospital of Guangzhou Medical University48